Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DUKE UNIVERSITY
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-06-14 to 2025-10-13
Current total value of award: $1457295
Description: THE GOAL OF THIS TASK ORDER IS TO PERFORM PHARMACOEPIDEMIOLOGY RESEARCH AND A PK, PHARMACODYNAMIC, PHARMACOGENOMIC, EFFICIENCY, AND SAFETY TRIAL OF THE HIGHEST RECOMMENDED DOSE OF SILDENAFIL IN PRETERM NEONATES (COHORT 3); WITH CLINICALLY RELEVANT OU